Neonatal Epileptic Encephalopathies

Samiya Fatima Ahmad1, Kaashif Aqeeb Ahmad2, Yu-Tze Ng1

  • 1Department of Pediatrics, Baylor College of Medicine, San Antonio, TX; The Children's Hospital of San Antonio, San Antonio, TX.

Insights

Neonatal seizures often stem from common causes, but epileptic encephalopathies demand prompt diagnosis. This review details benign and severe epilepsy syndromes, offering diagnostic and therapeutic strategies for better infant outcomes.

Area of Science:

  • Neonatology
  • Neurology
  • Pediatrics

Background:

  • Neonatal seizures are frequently linked to hypoxic-ischemic encephalopathy and intraventricular hemorrhage.
  • Neonatal epileptic encephalopathies, though less common, are critical seizure disorders requiring urgent attention.

Purpose of the Study:

  • To summarize benign and severe neonatal epilepsy syndromes.
  • To review diagnostic and therapeutic strategies for neonatal seizures.
  • To provide algorithms for the diagnosis and management of neonatal epilepsy.

Main Methods:

  • Literature review of neonatal seizure disorders.
  • Categorization of epilepsy syndromes into benign and severe types.
  • Synthesis of current diagnostic and therapeutic approaches.

Main Results:

  • Benign epilepsy syndromes generally have favorable prognoses.
  • Severe epilepsy syndromes are often associated with genetic disorders and poor outcomes.
  • Accurate diagnosis can prevent prolonged antiseizure medication treatment for benign forms.

Conclusions:

  • Distinguishing between benign and severe neonatal epilepsy is crucial for appropriate management.
  • Early diagnosis and intervention are key for improving outcomes in neonatal seizure disorders.
  • The review provides practical algorithms to guide clinical decision-making in neonatal epilepsy.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
886
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
744
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
896
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
648